Hemodiaz Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.06 Cr
as on 24-10-2024
- Company Age 26 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.37 Cr
as on 24-10-2024
- Satisfied Charges ₹ 4.50 M
as on 24-10-2024
- Revenue -56.42%
(FY 2023)
- Profit -40.90%
(FY 2023)
- Ebitda -4.94%
(FY 2023)
- Net Worth 10.57%
(FY 2023)
- Total Assets -0.81%
(FY 2023)
About Hemodiaz Life Sciences
The Corporate was formerly known as Shri Behari Lal Polymers Private Limited.. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.06 Cr.
The company currently has active open charges totaling ₹19.37 Cr. The company has closed loans amounting to ₹4.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rajni Dhawan and Ashish Dhawan serve as directors at the Company.
- CIN/LLPIN
U33111DL1998PTC095173
- Company No.
095173
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jul 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Hemodiaz Life Sciences Private Limited offer?
Hemodiaz Life Sciences Private Limited offers a wide range of products and services, including CPAP, BiPAP Machine & Accessories, BiPAP Machine, Surgical & ICU Equipments, Defibrillators, Medical Pumps, Patient Monitoring System, Diagnostic Medical Imaging Equipment, ECG Machine, Face Mask & Medical PPE Kits, Personal Protective Equipment.
Who are the key members and board of directors at Hemodiaz Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Dhawan  | Director | 27-Dec-2011 | Current |
| Rajni Dhawan | Director | 01-May-1999 | Current |
Financial Performance of Hemodiaz Life Sciences.
Hemodiaz Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 56.42% decrease. The company also saw a substantial fall in profitability, with a 40.9% decrease in profit. The company's net worth Soared by an impressive increase of 10.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hemodiaz Life Sciences?
In 2023, Hemodiaz Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asd Ad Media Solutions Private LimitedActive 20 years 8 monthsRajni Dhawan and Ashish Dhawan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Oct 2021 | ₹7.60 M | Open |
Others Creation Date: 27 Apr 2021 | ₹2.73 M | Open |
Others Creation Date: 17 Jul 2020 | ₹1.54 Cr | Open |
How Many Employees Work at Hemodiaz Life Sciences?
Hemodiaz Life Sciences has a workforce of 1 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hemodiaz Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemodiaz Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
